Hovione Names Vice-President of R&D
Hovione announced that it appointed a vice-president of R&D to work directly with client drug development projects.
On Jan. 12, 2015, Hovione announced that it appointed Filipe Gaspar, PhD, as vice-president of research and design (R&D) for the company. Gaspar, who will report to Hovione’s chief executive, Guy Villax, will lead teams that serve client drug development projects in Lisbon, Portugal, and New Jersey. Gaspar, a chemical engineer, joined Hovione in 2003 as a manufacturing engineer, and moved to R&D in 2004.
“We are very pleased to have Filipe running our R&D. Filipe brings great science and leadership skills. For the last 10 years Filipe has been the driving force behind our Particle Engineering, and if we have four new drugs today on the market it is because he and his team made sure we had the right capabilities, know-how and ability to deliver,” said Guy Villax in a press release.
Source: Hovione
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Drug Solutions Podcast: Emerging Methods of Vaccine Administration and Distribution
June 20th 2023Michael Schrader, CEO and co-founder of Vaxess, discusses the latest on vaccine administration and different ways the pharmaceutical industry can distribute these products with Pharmaceutical Technology editor Jill Murphy.
